A

Arbutus Biopharma Corp
D

ABUS

3.19000
USD
-0.03
(-0.93%)
مغلق
حجم التداول
13,382
الربح لكل سهم
-1
العائد الربحي
-
P/E
-7
حجم السوق
604,478,475
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ADVM
    0.05000
    (1.17%)
    4.33000 USD
    ALNY
    ALNY
    -2.740
    (-1.10%)
    246.360 USD
    A
    ARWR
    0.540
    (2.84%)
    19.560 USD
    BMY
    BMY
    -0.100
    (-0.18%)
    56.300 USD
    GILD
    GILD
    0.150
    (0.16%)
    91.790 USD
    MRNA
    MRNA
    0.310
    (0.92%)
    34.050 USD
    REGN
    REGN
    -11.37
    (-1.64%)
    681.49 USD
    V
    VBIV
    0
    (0.00%)
    0 USD
    VRTX
    VRTX
    4.97
    (1.19%)
    422.10 USD
    المزيد
الأخبار
المقالات

العنوان: Arbutus Biopharma Corp

القطاع: Healthcare
الصناعة: Biotechnology
Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commercializes cures for patients suffering from Hepatitis B infection. The company is focused on developing a portfolio of drug candidates with multiple mechanisms of action and is also involved in licensing Lipid nanoparticle technology.